Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover Experiment.
Journal: Metabolites
Published: January 01, 2024
Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
Journal: The Lancet. Digital health
Published: July 12, 2019
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.
Journal: Journal of lipid research
Published: November 30, 2017
Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level.
Journal: The American journal of cardiology
Published: August 08, 2016
Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Journal: The American journal of cardiology
Published: December 24, 2015
Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia.
Journal: Journal of clinical lipidology
Published: September 04, 2014
Clinical utility of low-density lipoprotein particles and apolipoprotein B in patients with cardiovascular risk.
Journal: The Journal of family practice
Published: August 20, 2013
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Journal: Journal of the American College of Cardiology
Published: April 04, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026